All-comer SENSE-PE registry will enroll up to 600 patients at up to 60 U.S. sites, measuring AVENTUS performance in everyday
AVENTUS Catheter combines 360° directional aspiration, TrueClot™ tissue sensing, and autologous blood return for exceptional control over clot removal MENLO
Strategic investment follows a transformative year marked by the national launch of the AVENTUS thrombectomy system. MENLO PARK, Calif.–(BUSINESS WIRE)–Inquis
June 16, 2025 09:30 ET – Pioneering device combines precision clot removal with autologous blood reinfusion to address unmet needs
May 02, 2025 11:50 ET – Results of AVENTUS IDE Trial presented at SCAI Scientific Sessions Inquis Medical, a leading
MENLO PARK, Calif. — January 13, 2025 – Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced
November 26, 2024 – A case example highlights the function of the AVENTUS System for the removal of emboli and
Nov 4, 2024 2:20 PM EST – MENLO PARK, Calif.–(BUSINESS WIRE)–Inquis Medical, a pioneering medical technology company specializing in advanced
July 9, 2024 – With Steven Abramowitz, MD; Mehdi H. Shishehbor, DO, MPH, PhD; and Nora Tabori, MD What are
